Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « achieved »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
achieve < achieved < achievement  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]
Ident.Authors (with country if any)Title
000047 (2012) N. Schütz [Allemagne] ; E. M Rker-Hermann [Allemagne]Rheumatoide Arthritis und multiples Myelom als Komorbidität
000049 (2012) Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000060 (2013) Francesco Caso [Italie] ; Luca Iaccarino [Italie] ; Silvano Bettio [Italie] ; Francesca Ometto [Italie] ; Luisa Costa [Italie] ; Leonardo Punzi [Italie] ; Andrea Doria [Italie]Refractory pemphigus foliaceus and Behçet’s disease successfully treated with tocilizumab
000066 (2013) Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000080 (2012) M. Licht [Allemagne] ; U. Kyank [Allemagne] ; C. Kneitz [Allemagne]Therapierefraktäre Polyarthritis und Fieber
000083 (2012) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon]The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
000089 (2013) Alfredo Adán [Espagne] ; Marina Mesquida [Espagne] ; Victor Llorenç [Espagne] ; Gerard Espinosa [Espagne] ; Blanca Molins [Espagne] ; Maria V. Hernández [Espagne] ; Laura Pelegrín [Espagne]Tocilizumab treatment for refractory uveitis-related cystoid macular edema
000094 (2011) Maasa Hama [Japon] ; Takeaki Uehara [Japon] ; Kaoru Takase [Japon] ; Atsushi Ihata [Japon] ; Atsuhisa Ueda [Japon] ; Mitsuhiro Takeno [Japon] ; Kazuya Shizukuishi [Japon] ; Ukihide Tateishi [Japon] ; Yoshiaki Ishigatsubo [Japon]Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data
000098 (2012) H.-I. Huppertz [Allemagne]Biologika bei Kindern und Jugendlichen zur Behandlung rheumatischer Erkrankungen
000154 (2011) Atsushi Kaneko [Japon] ; Daihei Kida [Japon] ; Kiwamu Saito [Japon] ; Masami Tsukamoto [Japon] ; Tomotaro Sato [Japon]Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI
000228 (2012) Tomoyuki Imagawa [Japon] ; Syuji Takei [Japon] ; Hiroaki Umebayashi [Japon] ; Kenichi Yamaguchi [Japon] ; Yasuhiko Itoh [Japon] ; Toshinao Kawai [Japon] ; Naomi Iwata [Japon] ; Takuji Murata [Japon] ; Ikuo Okafuji [Japon] ; Mari Miyoshi [Japon] ; Yasuhiro Onoe [Japon] ; Yoshifumi Kawano [Japon] ; Noriko Kinjo [Japon] ; Masaaki Mori [Japon] ; Neelufar Mozaffarian [États-Unis] ; Hartmut Kupper [Allemagne] ; Sourav Santra [Inde] ; Gina Patel [États-Unis] ; Shinichi Kawai [Japon] ; Shumpei Yokota [Japon]Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
000241 (2010) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon]Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study
000306 (2013) Pavel Horák [République tchèque] ; Martina Skácelová [République tchèque] ; Karel Hejduk [République tchèque] ; Andrea Smržová [République tchèque] ; Karel Pavelka [République tchèque]Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry
000437 (2013) K. Hanami [Japon] ; K. Saito [Japon] ; H. Tasaka [Japon] ; Y. Tanaka [Japon]AB0546 Clinical and functional remission based on newly defined ACR/EULAR remission criteria achieved with tocilizumab in patients with rheumatoid arthritis
000533 (2009) E. Choy [Royaume-Uni] ; N. Sattar [Royaume-Uni]Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
000794 (2010) I. Kötter [Allemagne] ; G. Horneff [Allemagne]IL-1-Antagonisten
000795 (2007) J. Smolen [Autriche] ; D. Aletaha [Autriche]The burden of rheumatoid arthritis and access to treatment: a medical overview
000805 (2013) F. Speth [Allemagne] ; N. Wellinghausen [Allemagne] ; J.-P. Haas [Allemagne]Medikamentöse Prophylaxe während intensivierter Immunsuppression bei Kindern und Jugendlichen
000875 (2012) Nicolino Ruperto [Italie] ; Pierre Quartier [France] ; Nico Wulffraat [Pays-Bas] ; Patricia Woo [Royaume-Uni] ; Angelo Ravelli [Italie] ; Richard Mouy [France] ; Brigitte Bader-Meunier [France] ; Sebastiaan J. Vastert [Pays-Bas] ; Emanuele Noseda [Suisse] ; Daniele D'Ambrosio [Suisse] ; Jean Lecot [Suisse] ; Abhijit Chakraborty [Suisse] ; Alberto Martini [Italie] ; Andrea Chioato [Suisse]A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
000880 (2012) Metin Isik [Turquie] ; Burcin Halacli [Turquie] ; Özgür Atmaca [Turquie] ; Sezgin Etgül [Turquie] ; Smail Do An [Turquie] ; Levent K L Nç [Turquie] ; Meral Çalgüneri [Turquie]Triple DMARD combination for rheumatoid arthritis resistant to methotrexate and steroid combination: a single-center experience
000A38 (2010) T. Schmeiser [Allemagne] ; U. Müller- Ladner [Allemagne]Therapie mit Certolizumab pegol bei Patienten mit destruierender Arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "achieved" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "achieved" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    achieved
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021